2025 International Congress Archives - Page 6 of 181

A personalized gait signature assay in Parkinson’s disease

H. Babcock, J. Stephen, V. Vanderhorst (Boston, USA)
A Phase 1b Study to Investigate Safety and Tolerability of Repeated Subcutaneous Doses of HER-096 in Subjects with Parkinson’s Disease

K. Holmström, K. Jääskeläinen, N. Kulesskaya, J. Koskinen, R. Holmnäs, A. Vuolanto, A. Domanska, M. Engström, P. Vainio, M. Scheinin, C. Videbaek, A. Tornio, Z. Lovro, F. Scheperjans, J. Rinne, H. Huttunen (Espoo, Finland)
A Phase 2 Study of Risvodetinib in Untreated Parkinson’s Disease

M. Werner, C. Meyer, E. Mancino, C. Klint, J. Pellecchia, A. Mcgarry, K. Kieburtz, C. Olanow (Atlanta, USA)
A Phase I Study of TR-012001, a Nasal Levodopa, in Healthy Adult Japanese Male Subjects

R. Ise, M. Kaneko, S. Haruta, Y. Sonoda, Y. Akiyoshi, C. Date, S. Nakano, T. Akagi, Y. Sumiyoshi, S. Kanazashi, I. Nagata, H. Fukase (Tokyo, Japan)
A Phase II Randomized, Parallel, Double-blind, Placebo-controlled Study of the Efficacy and Safety of WD-1603 in Subjects with Parkinson’s Disease

X. Wei, L. Chen, X. Hu, J. Guo, C. Liu, J. Wang (Shanghai, China)
A Proof-of-Concept Study of TR-012001, a Nasal Levodopa, in Patients With Parkinson’s Disease With OFF Episodes, Without Dopa Decarboxylase Inhibitor

M. Nomoto, H. Yabe, R. Ando, Y. Sumiyoshi, T. Akagi, R. Ise, Y. Akiyoshi, C. Date, S. Nakano, R. Suzuki, Y. Sonoda, S. Haruta, S. Kanazashi, A. Mori, I. Nagata (Tokyo, Japan)
A Prospective, Observational Study to Identify Biomarkers in Parkinsonian Syndromes (proATYP).

M. Makrygianni, D. Potamianou, T. Pipikos, M. Xilouri, C. Mourmouris, A. Sarafi, L. Florentin, M. Stamelou (Athens, Greece)
A Qualitative Approach to Extract Diagnostic Patterns of Cognitive Impairment in Parkinson’s Disease

A. Eubank, A. Thatikala, M. Garza, H. Khan, T. Virmani, R. Dhall, J. Talburt, L. Larson-Prior, F. Prior (Little Rock, USA)
A Quantitative Analysis of the Link between Weight Gain and Charge Efficiency in DBS

C. O'Keeffe, F. Ruggieri, E. Donlon, A. Mathew, C. Moran, R. Walsh (Dublin, Ireland)
A Quantitative Systems Disease Model for Progressive Supranuclear Palsy.

H. Geerts, S. Short (Radnor, USA)

« Previous Page
1
…
4
5
6
7
8
…
181
Next Page »